Jalpa A. Doshi, PhD

faculty photo
Leon Hess Professor in Internal Medicine
Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania
Fellow, Institute on Aging, University of Pennsylvania
Director, Value Based Insurance Design Initiatives, Center for Health Incentives and Behavioral Economics, University of Pennsylvania
Director, Economic Evaluations Unit, Center for Evidence-Based Practice, University of Pennsylvania Health System
Associate Director , ECRI-Penn Medicine Evidence-based Practice Center (EPC) funded by the Agency for Healthcare Research and Quality
Senior Fellow, Center for Public Health Initiatives, University of Pennsylvania
Department: Medicine

Contact information
1223 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104
Office: (215) 898-7989
Education:
BPharm (Pharmaceutical Sciences)
Bombay College of Pharmacy, University of Bombay (Mumbai), India, 1999.
MS (Pharmaceutical Health Services Research)
University of Maryland, Baltimore, 2001.
PhD (Pharmaceutical Health Services Research)
University of Maryland, Baltimore, 2003.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Dawit R, Goedel WC, Chang HY, Nunn AS, Chan PA, Doshi JA, Dean LT: County-level factors associated with reversal of insurer-approved HIV pre-exposure prophylaxis prescriptions in the United States, 2018. AIDS and Behavior December 2024 Notes: In Press.

Shafrin J, Kim J, Cohen JT, Garrison LP, Goldman DA, Doshi JA, Krieger J, Lakdawalla DN, Neumann PJ, Phelps CE, Whittington MD, Willke R: "Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices" Forum Health Econ Policy 27(1): 29-116, November 2024.

Bakre S, Chang H, Doshi JA, Goedel WC, Saberi P, Chan PA, Nunn A, Dean LT: "Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments" JAMA Internal Medicine 184(10): 1204-1211, October 2024.

Klebanoff MJ, Li P, Chatterjee P, Doshi JA: "Real-Time Prescription Benefit Tool Adoption Among US Hospitals" JAMA Health Forum 5(10): e243181, October 2024.

Klebanoff MJ, Li P, Lin JK, Doshi JA: "Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans" JAMA 332(1): 74-76, July 2024.

Garg M, Puckett J, Kamal-Bahl S, Raut M, Ryland KE, Doshi JA, Huntington SF: "Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting" Clinical Lymphoma, Myeloma, and Leukemia 24(5): e181-e190, May 2024.

Doshi JA, Li P, Geng Z, Seo S, Patel C, Benson C : "Out-of-Pocket Costs for Long-Acting Injectable and Oral Antipsychotics Among Medicare Patients With Schizophrenia" Psychiatric Services 75(4): 333-341, April 2024.

Dean L, Nunn AS, Chang HY, Goedel WC, Chan PA, Doshi JA: "Estimating the Impact of Out-of-Pocket Cost Changes on the Abandonment of HIV Pre-exposure Prophylaxis (PrEP) Prescriptions" Health Affairs 43(1): 36-45, April 2024.

Dawit R, Goedel WC, Reid SC, Doshi JA, Nunn AS, Chan PA, Dean LT: "Geographic Variation of PrEP Reversal and Abandonment across the United States" AIDS 38(4): 557-566, March 2024.

Li P, Prajapati G, Geng Z, Ladage V, Arduino JM, Watson D, Gross R, Doshi JA: "Antiretroviral Treatment Gaps and Adherence Among People with HIV in the U.S. Medicare Program" AIDS and Behavior 28(3): 1002-1014, March 2024.

back to top
Last updated: 12/16/2024
The Trustees of the University of Pennsylvania